Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00742183 · ClinicalTrials.gov registry record · NA
Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®
A NA study of Second Degree Burn, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 10
- Study locations
NCT00742183 is a NA study of Second Degree Burn that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 100 participants. The trial reports 10 study locations across 10 states.
The verdict
NCT00742183, a NA study of Second Degree Burn, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 10
- Study locations
Study Summary
The primary objective is to compare the incremental costs (direct and indirect) and benefits (healing outcomes, quality of life) of using foam silver dressing (Mepilex® Ag) to a Silver sulfadiazine 1% cream (Silvadene®) from the perspective of the health care provider. The secondary objectives are to investigate the safety, the tolerance and the performance on burn status including pain.
Conditions Studied
Interventions
- DEVICE Mepilex
- DEVICE Silvadene
Study Locations (10)
California
- LA County Hospital & USC Medical Center - Los Angeles
District of Columbia
- The Burn Center, Washington Hospital Center - Washington D.C.
Florida
- Shands Burn Center, University of Florida - Gainesville
Georgia
- Joseph Still Burn Center - Augusta
Iowa
- UI Burn Treatment center - Iowa City
New York
- Cornell Medical Center - New York
Oklahoma
- Paul Silverstein Burn center - Oklahoma City
Pennsylvania
- St Christopher's Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00742183
The ClinicalTrials.gov registry entry for NCT00742183 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Second Degree Burn appearing as the primary indexed condition, and to 2 interventions - of which Mepilex is the first listed.
NCT00742183 reports 10 study locations spanning 10 distinct geographic areas - top geographies include California, District of Columbia, Florida.
Frequently Asked Questions
What is clinical trial NCT00742183 about?
NCT00742183 is a clinical study titled "Evaluating the Cost-effectiveness, Efficacy, Safety and Tolerance of Mepilex® Ag Versus Silvadene®". The primary objective is to compare the incremental costs (direct and indirect) and benefits (healing outcomes, quality of life) of using foam silver dressing (Mepilex® Ag) to a Silver sulfadiazine 1% cream (Silvadene®) from the perspective of the health care provider. The secondary objectives are ...
What is the current status of trial NCT00742183?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2008-08. Estimated completion is 2009-11.
What conditions does trial NCT00742183 study?
This clinical trial studies the following conditions: Second Degree Burn.
What interventions are being tested in trial NCT00742183?
The interventions under investigation include: Mepilex (DEVICE), Silvadene (DEVICE).
Who is sponsoring clinical trial NCT00742183?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00742183 being conducted?
This trial has 10 study locations across California, District of Columbia, Florida, Georgia, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Second Degree Burn
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.